Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases

Abstract In case of AAV with kidney involvement, physicians should explore anti‐GBM antibodies and be aware of the possible sequential development of AAV, especially with MPO‐ANCA, and anti‐GBM glomerulonephritis. This sequential disease history is associated with a poor renal outcome, highlighting...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Camille Le Moine, Noémie Jourde‐Chiche, Delphine Kemlin, Benjamin Terrier, Frédéric Vandergheynst
Formato:	Artigo
Idioma:	English
Publicado em:	Wiley 2021-07-01
Colecção:	Clinical Case Reports
Assuntos:	ANCA‐associated vasculitis anti‐GBM disease glomerulonephritis myeloperoxidase
Acesso em linha:	https://doi.org/10.1002/ccr3.4553

Registos relacionados

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
Por: N M Bulanov, et al.
Publicado em: (2018-06-01)

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
Por: Xueling Hu, et al.
Publicado em: (2022-10-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
Por: Precil Diego Miranda de Menezes Neves, et al.
Publicado em: (2021-08-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
Por: Valentine Gillion, et al.
Publicado em: (2017-03-01)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
Por: Afroditi Maria Konstantouli, et al.
Publicado em: (2022-09-01)

Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report
Por: Takuya Yamazaki, et al.
Publicado em: (2023-07-01)

Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
Por: Florian Garo, et al.
Publicado em: (2022-04-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
Por: Ana Teresa Domingos, et al.
Publicado em: (2019-10-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
Por: Naohiro Yoshida, et al.
Publicado em: (2014-01-01)

Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study
Por: Adam D. Morris, et al.
Publicado em: (2022-04-01)

Three Diseases Mediated by Different Immunopathologic Mechanisms—ANCA-Associated Vasculitis, Anti-Glomerular Basement Membrane Disease, and Immune Complex-Mediated Glomerulonephritis—A Common Clinical and Histopathologic Picture: Rapidly Progressive Crescentic Glomerulonephritis
Por: Cristina Gluhovschi, et al.
Publicado em: (2023-11-01)

An unusual cause of rapidly progressive glomerulonephritis associated with ANCA vasculitis and ovarian malignancy – a relapse 39 years after initial treatment
Por: Nikola Simovic, et al.
Publicado em: (2023-07-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
Por: D. Bele, et al.
Publicado em: (2020-01-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
Por: Désirée Tampe, et al.
Publicado em: (2021-09-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
Por: Rui Wu, et al.
Publicado em: (2021-03-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
Por: Dario Roccatello, et al.
Publicado em: (2022-03-01)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
Por: Wei Lin, et al.
Publicado em: (2021-03-01)

Complement Inhibition in ANCA-Associated Vasculitis
Por: Vladimir Tesar, et al.
Publicado em: (2022-07-01)

ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
Por: Michalis Christodoulou, et al.
Publicado em: (2022-07-01)

Treatment of renal manifestations of ANCA-associated vasculitis
Por: Kresimir Galesic, et al.
Publicado em: (2013-01-01)

Environmental factors influencing the risk of ANCA-associated vasculitis
Por: Wen-Man Zhao, et al.
Publicado em: (2022-09-01)

Presentation and progression of MPO-ANCA interstitial lung disease
Por: Lorenzo Salvati, et al.
Publicado em: (2024-06-01)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
Por: Samy Hakroush, et al.
Publicado em: (2021-10-01)

Clinical Phenotype and Outcomes of Indo-Asian Patients with ANCA-Associated Glomerulonephritis in the North West, UK
Por: Lauren Floyd, et al.
Publicado em: (2023-11-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
Por: Nankee K. Kumar, AB, et al.
Publicado em: (2024-03-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
Por: A. V. Burlutskaya, et al.
Publicado em: (2020-10-01)

A case of COVID‐19‐associated C‐ANCA vasculitis, was successfully treated with rituximab therapy
Por: Michael Filoramo, et al.
Publicado em: (2024-08-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
Por: Kazuhiro Kitamoto, et al.
Publicado em: (2023-08-01)

Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
Por: Zhonghua Liao, et al.
Publicado em: (2021-07-01)

Update of Management of ANCA-Associated Vasculitis
Por: Hoi San Tang, et al.
Publicado em: (2021-12-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
Por: Marinchev Liubomir, et al.
Publicado em: (2013-10-01)

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
Por: Aglaia Chalkia, et al.
Publicado em: (2020-01-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
Por: Zachary S. Wallace, et al.
Publicado em: (2019-12-01)

Rapidly progressive glomerulonephritis and ANCA-negative pauci-immune vasculitis: an unusual presentation. A case report
Por: Zitlali Guadalupe Paulín Zepeda, et al.
Publicado em: (2023-09-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
Por: Charmaine van Eeden, et al.
Publicado em: (2023-04-01)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
Por: Laura S. van Dam, et al.
Publicado em: (2020-12-01)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
Por: Claire Harris, et al.
Publicado em: (2018-06-01)

Impact of ANCA-Associated Vasculitis on Outcomes of Hospitalizations for Goodpasture’s Syndrome in the United States: Nationwide Inpatient Sample 2003–2014
Por: Charat Thongprayoon, et al.
Publicado em: (2020-03-01)

ANCA-associated Leucocytoclastic Vasculitis presenting with Bronchiectasis, GI Involvement and Hypertensive Urgency: A Complex Case without Renal Involvement
Por: N. M. M. Risly, et al.
Publicado em: (2024-12-01)

Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study
Por: Aya Kawasaki, et al.
Publicado em: (2020-10-01)